Literature DB >> 19849777

Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma.

Teh-Ia Huo1, Chia-Yang Hsu, Yi-Hsiang Huang, Cheng-Yuan Hsia, Han-Chieh Lin, Pui-Ching Lee, Che-Chuan Loong, Jen-Huey Chiang, Yi-You Chiou, Shou-Dong Lee.   

Abstract

BACKGROUND: Patients with hepatocellular carcinoma (HCC) often have coexisting cirrhosis, which may predispose to the development of diabetes mellitus (DM). Diabetic HCC patients may have renal insufficiency and a subsequent worse outcome. This study investigated the interaction between DM, cirrhosis and renal dysfunction and the impact of these factors on HCC.
METHODS: A prospective database of 1713 HCC patients was analysed.
RESULTS: A total of 392 (22.9%) patients were diabetic. Diabetic patients had a significantly higher Child-Turcotte-Pugh (CTP) score, model for end-stage liver disease score and serum creatinine level, but had significantly lower serum albumin, sodium, alanine aminotransferase, aspartate aminotransferase and bilirubin levels. The serum creatinine level progressively increased and correlated well with increasing CTP class in both diabetic and non-diabetic patients. After a mean follow-up of 18+/-16 months, DM was shown to be an independent predictor of mortality in the Cox proportional hazard model after adjusting for other predictors [hazard ratio (HR): 1.2, 95% confidence interval (CI): 1.02-1.42]. Diabetic patients more often had renal insufficiency, defined as serum creatinine>1.5 mg/dl (17.3 vs 8.3%, P<0.0001). Renal insufficiency was an independent prognostic predictor in diabetic patients (HR: 2.26, 95% CI: 1.57-3.24) but not in non-diabetic patients, because it was significantly associated with the severity of cirrhosis in the non-diabetic group (P<0.001) but not in the diabetic group (P=0.143).
CONCLUSIONS: DM is associated with inadequate liver reserve and independently predicts decreased survival in HCC patients. Both advanced cirrhosis and DM are associated with renal insufficiency, which is a poor prognostic predictor for HCC.

Entities:  

Mesh:

Year:  2009        PMID: 19849777     DOI: 10.1111/j.1478-3231.2009.02143.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  13 in total

1.  Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.

Authors:  Wen-Yi Shau; Yu-Yun Shao; Yi-Chun Yeh; Zhong-Zhe Lin; Raymond Kuo; Chih-Hung Hsu; Chiun Hsu; Ann-Lii Cheng; Mei-Shu Lai
Journal:  Oncologist       Date:  2012-05-23

2.  Ascites in patients with hepatocellular carcinoma: prevalence, associated factors, prognostic impact, and staging strategy.

Authors:  Chia-Yang Hsu; Yun-Hsuan Lee; Yi-Hsiang Huang; Cheng-Yuan Hsia; Chien-Wei Su; Han-Chieh Lin; Rheun-Chuan Lee; Yi-You Chiou; Fa-Yauh Lee; Teh-Ia Huo; Shou-Dong Lee
Journal:  Hepatol Int       Date:  2012-01-08       Impact factor: 6.047

3.  Hepatogenous diabetes: Is it a neglected condition in chronic liver disease?

Authors:  Diego García-Compeán; José Alberto González-González; Fernando Javier Lavalle-González; Emmanuel Irineo González-Moreno; Jesús Zacarías Villarreal-Pérez; Héctor Jesús Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

4.  ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategy.

Authors:  Shu-Yein Ho; Po-Hong Liu; Chia-Yang Hsu; Chih-Chieh Ko; Yi-Hsiang Huang; Chien-Wei Su; Cheng-Yuan Hsia; Rheun-Chuan Lee; Ming-Chih Hou; Teh-Ia Huo
Journal:  J Gastrointest Oncol       Date:  2021-04

5.  The functional cancer map: a systems-level synopsis of genetic deregulation in cancer.

Authors:  Markus Krupp; Thorsten Maass; Jens U Marquardt; Frank Staib; Tobias Bauer; Rainer König; Stefan Biesterfeld; Peter R Galle; Achim Tresch; Andreas Teufel
Journal:  BMC Med Genomics       Date:  2011-06-30       Impact factor: 3.063

6.  The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

Authors:  Wan-Shui Yang; Puthiery Va; Freddie Bray; Shan Gao; Jing Gao; Hong-Lan Li; Yong-Bing Xiang
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

7.  Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Jiangguo Zhang; Fengyun Gong; Ling Li; Manzhi Zhao; Jianxin Song
Journal:  Oncol Lett       Date:  2014-02-20       Impact factor: 2.967

Review 8.  Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Yan-Gang Wang; Peng Wang; Bin Wang; Zheng-Ju Fu; Wen-Juan Zhao; Sheng-Li Yan
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

9.  Glycogen synthase kinase-3β is associated with the prognosis of hepatocellular carcinoma and may mediate the influence of type 2 diabetes mellitus on hepatocellular carcinoma.

Authors:  Guoliang Qiao; Yuan Le; Jun Li; Lianghuan Wang; Feng Shen
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

10.  Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.

Authors:  Yu-Wen Su; Po-Hong Liu; Chia-Yang Hsu; Yun-Hsuan Lee; Cheng-Yuan Hsia; Shu-Yein Ho; Ming-Chih Hou; Harn-Shen Chen; Teh-Ia Huo
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.